The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring HER2 amplification (JUPITER trial).
 
Ryo Kudo
No Relationships to Disclose
 
Toshio Kubo
No Relationships to Disclose
 
Yukiko Mori
No Relationships to Disclose
 
Yohei Harada
No Relationships to Disclose
 
Hidekazu Shirota
No Relationships to Disclose
 
Hideyuki Hayashi
No Relationships to Disclose
 
Masayuki Kano
No Relationships to Disclose
 
Yasushi Shimizu
No Relationships to Disclose
 
Eri Ishibashi
No Relationships to Disclose
 
Hirotoshi Akita
No Relationships to Disclose
 
Hisahiro Matsubara
No Relationships to Disclose
 
Hiroshi Nishihara
No Relationships to Disclose
 
Chikashi Ishioka
Honoraria - Asahi Kasei; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Konica Minolta; Kyowa; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Mundipharma; Nihonkayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Teijin Pharma; Teijin Pharma; Yakult Honsha
Research Funding - Asahi Kasei (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kissei Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD K.K (Inst); Nihonkayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Naoko Sueoka-Aragane
No Relationships to Disclose
 
Manabu Muto
Research Funding - Chugai Pharma
 
Shinichi Toyooka
Honoraria - Chugai Pharma
 
Ukihide Tateishi
No Relationships to Disclose
 
Akihiro Hirakawa
Honoraria - Chugai Pharma
 
Satoshi Miyake
No Relationships to Disclose
 
Sadakatsu Ikeda
Honoraria - Chugai Pharma